The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from PR Newswire

Boston Scientific to Participate in Leerink Swann 2012 Global Healthcare Conference

Tuesday, February 07, 2012

Boston Scientific to Participate in Leerink Swann 2012 Global Healthcare Conference14:00 EST Tuesday, February 07, 2012NATICK, Mass., Feb. 7, 2012 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Leerink Swann 2012 Global Healthcare Conference on February 15 in New York.Hank Kucheman, Chief Executive Officer, Mike Mahoney, President, and Jeff Capello, Executive Vice President and Chief Financial Officer, will participate in a 30-minute question and answer session regarding the Company beginning at approximately 11:00 a.m. ET.A live webcast of the question and answer session will be available to all interested parties via Boston Scientific's website.  Webcast registration is available on the Investor Relations section of the website at www.bostonscientific.com/investors.  Interested parties are encouraged to register at least 15 minutes prior to the scheduled start time to ensure a timely connection.This webcast is being hosted by Leerink Swann.  The replay will be archived and available at www.bostonscientific.com/investors beginning approximately one hour following the completion of the question and answer session.About Boston ScientificBoston Scientific is a worldwide developer, manufacturer and marketer of medical devices that are used in a broad range of interventional medical specialties.  For more information, please visit: www.bostonscientific.com.   CONTACT:  Denise Kaigler 508-650-8330 (office) Media Relations Boston Scientific Corporation denise.kaigler@bsci.com   Eric Olson 336-293-4393 (office) Media Relations Boston Scientific Corporation eric.olson@bsci.com   Sean Findlen 617-520-7268 (office) Media Relations Weber Shandwick sfindlen@webershandwick.com   Sean Wirtjes 508-652-5305 (office) Investor Relations Boston Scientific Corporation Investor_Relations@bsci.comSOURCE Boston Scientific Corporation